Original article
A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients
Ensayo en fase 2, doble ciego, controlado con placebo, para evaluar un tratamiento combinado con valproato y litio en pacientes con ELA
M.-C. Bolla,
, M. Alcaraz-Zubeldiab, C. Riosb, D. González-Esquiveld, S. Montesb
Corresponding author
a Clinical Research Laboratory, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), Tlalpan, México
b Department of Neurochemistry, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), Tlalpan, México
d Division of Pharmacology, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNNMVS), Tlalpan, México
Read
5054
Timeswas read the article
1273
Total PDF
3781
Total HTML
Article information
ISSN: 21735808Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 9 | 56 | 12 | 68 |
| 2026 8 | 111 | 46 | 157 |
| 2026 7 | 279 | 36 | 315 |
| 2026 6 | 131 | 36 | 167 |
| 2026 5 | 101 | 40 | 141 |
| 2026 4 | 121 | 42 | 163 |
| 2026 3 | 140 | 39 | 179 |
| 2026 2 | 130 | 50 | 180 |
| 2026 1 | 211 | 73 | 284 |
| 2025 12 | 192 | 72 | 264 |
| 2025 11 | 145 | 91 | 236 |
| 2025 10 | 101 | 39 | 140 |
| 2025 9 | 76 | 43 | 119 |
| 2025 8 | 96 | 29 | 125 |
| 2025 7 | 143 | 28 | 171 |
| 2025 6 | 87 | 27 | 114 |
| 2025 5 | 88 | 18 | 106 |
| 2025 4 | 88 | 27 | 115 |
| 2025 3 | 83 | 21 | 104 |
| 2025 2 | 93 | 47 | 140 |
| 2025 1 | 74 | 17 | 91 |
| 2024 12 | 61 | 15 | 76 |
| 2024 11 | 80 | 32 | 112 |
| 2024 10 | 39 | 18 | 57 |
| 2024 9 | 64 | 31 | 95 |
| 2024 8 | 50 | 40 | 90 |
| 2024 7 | 64 | 20 | 84 |
| 2024 6 | 46 | 11 | 57 |
| 2024 5 | 56 | 13 | 69 |
| 2024 4 | 67 | 23 | 90 |
| 2024 3 | 50 | 17 | 67 |
| 2024 2 | 50 | 14 | 64 |
| 2024 1 | 75 | 19 | 94 |
| 2023 12 | 34 | 8 | 42 |
| 2023 11 | 47 | 17 | 64 |
| 2023 10 | 49 | 10 | 59 |
| 2023 9 | 54 | 22 | 76 |
| 2023 8 | 92 | 9 | 101 |
| 2023 7 | 45 | 9 | 54 |
| 2023 6 | 52 | 19 | 71 |
| 2023 5 | 91 | 18 | 109 |
| 2023 4 | 69 | 13 | 82 |
| 2023 3 | 0 | 33 | 33 |
| 2023 2 | 0 | 10 | 10 |
| 2023 1 | 0 | 11 | 11 |
| 2022 12 | 0 | 8 | 8 |
Show all
